Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis

Growth Hormone and IGF Research

Volumn 9, Issue 2, 1999, Pages 131-142

  Stewart, C E H ^a   Newcomb, P V ^a   Savage, P B ^a   Dickens, M ^a   Tavare, J ^a   Holly, J M P ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apoptosis; Ceramide; Insulin like growth factor I signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CERAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TYROSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033136372     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1999.0098     Document Type: Article

References (33)

1. Cuvillier O, Piranov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381: 800-803.
2. Xia Z, Dickens M, Raingeaud M, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
3. Rinderknecht E, Humbel RE. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: Evidence for structural homology with insulin B chain. Proc Natl Acad Sci USA 1976; 73: 4379-4381.
4. Cheatham B, Kahn CR. Insulin action and the insulin signalling network. Endocrine Reviews 1995; 16: 117-142.
5. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr, CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995; 16: 143-163.
6. Baserga R, Rubin R. Cell cycle and growth control. Crit Rev Eukaryotic Gene Expression 1993; 3: 47-61.
7. Stewart CEH, Rotwein P. Growth, differentiation, and survival: Multiple physiological functions of insulin-like growth factors. Physiol Rev 1996; 76: 1005-1026.
8. Baker J, Liu J-P, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82.
9. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type I IGF receptor (IGFIR). Cell 1993; 75: 59-72.
10. Florini JR, Ewton DZ, Mcwade FJ. IGFs, muscle growth, and myogenesis. Diabetes Rev 1995; 3: 73-92.
11. Stewart CEH, James PL, Fant ME, Rotwein P. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J Cell Phys 1996; 169: 23-32.
12. Stewart CEH, Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996; 271: 11330-11338.
13. Liscovitch M, Cantley LC. Lipid second messengers. Cell 1994; 77: 329-334.
14. Spiegel S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Curr Opin Cell Biol 1996; 8: 159-167.
15. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 1996; 274: 1855-1859.
16. Gill ZP, Perks CM, Newcomb PV, Holly JMP. Insulin-like growth factor binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF dependent manner. J Biol Chem 1997; 272: 25602-25607.
17. Skowronski EW, Kolesnik RN, Green DR. Fas-mediated apoptosis and sphingomyelinase signal transduction: The role of ceramide as a second messenger for apoptosis. Cell Death Diff 1996; 3: 171-176.
18. Obeid LM, Hannun YA. Ceramide: A stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 1995; 58: 191-198.
19. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259:1769-1771.
20. Kanety H, Hemi R, Papa MZ, Karasik A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 1996; 271: 9895-9897.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
22. Kerr JFR, Winterford CM. Apoptosis, its significance in cancer and cancer therapy. Cancer 1993; 73: 2013-2026.
23. Raines MA, Kolesnick RN, Golde DW. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993; 268: 14572-14575.
24. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Yu. Pushkareva, M, Obeid LM, Hannun YA. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270: 2047-2052.
25. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994; 91: 73-77.
26. Coroneos E, Wang Y, Panuska JR, Templeton DJ, Kester M. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem J 1996; 316: 13-17.
27. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer M, Szabo E, Zon LI, Kyriakis JM, Haimovits-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-79.
28. McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol 1994; 4: 370-375.
29. Yao R, Cooper GM. Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.
30. Pyne S, Tolan DG, Conway A.-M. Pyne, N. Lipids as regulators of cell function. Biochem Soc Trans 1997;25:549-556.
31. cdc2 activation required for apoptosis. Science 1994; 263: 1143-1145.
32. Zundel W, Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev 1998; 12: 1941-1946.
33. Zhou H, Summers SA, Birnbaum MJ, Pittman RN. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 1998; 273: 16568-16575.